Archives

Aston University celebrated its 50th Anniversary with a packed programme of events and initiatives for its alumni, staff, students and

For up to US$685m (€606m), Dutch ArgenX has outlicensed its human antibody programme ARGX-115 to AbbVie. The pre-clinical immuno-oncology candidate

The US government is forking out up to US$100m to get Basilea Pharmaceutica’s broad-spectrum antibiotic ceftobiprole on the US market.

An Aston study reveals parents who use very overly controlling feeding practices with their children could be unintentionally teaching their

British drug developer Heptares Therapeutics and mAb maker Kymab Ltd have partnered up in yet another immuno-oncology collaboration. The companies

Despite political disturbances, 2015 was a good year for the biotech scene in Switzerland. Net sales increased by 5.1% to

Pfizer and Allergan have called off their merger, cancelling plans to relocate the US pharma giant to Ireland to avoid

In early April, the Committee for Medicinal Products for Human Use (CHMP) gave GSK recommended approval for its gene therapy

British CRO Fusion Antibodies and German MAB Discovery, a specialist in the discovery of unique antibodies, have joined forces to

Two major UK biotechs are about to consolidate after respiratory drugmaker Vectura has agreed to acquire drug delivery specialist SkyePharma